MARK SCHULTZ: Open Payments
NPI 1235438433 · KEAAU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 14 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $35 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $150 |
| E.R. Squibb & Sons, L.L.C. | 1 | $144 |
| Teva Pharmaceuticals USA, Inc. | 1 | $108 |
| Vanda Pharmaceuticals Inc. | 2 | $74 |
| SK Life Science, Inc. | 2 | $58 |
| JAZZ PHARMACEUTICALS INC. | 2 | $58 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
| UCB, Inc. | 1 | $33 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
Products named: ABILIFY MAINTENA, COBENFY, UZEDY, PONVORY, XYWAV, ACTHAR, Rystiggo, LUMRYZ.
Industry payments across HI — which companies pay providers there.
